Eli Lilly Eyes Obesity Access Expansion With Zepbound, Foundayo and Pipeline Bets
The company said demand for oral obesity drugs is expanding the market as 60% to 70% of Medicare pilot patients are new to weight-loss treatments.
7 Articles
7 Articles
Lilly says Foundayo has captured over 30% of new US patients on oral weight-loss drugs - Regional Media News
By Mariam Sunny Sept 14 (Reuters) - Eli Lilly on Monday said it has captured more than 30% of new patients in the U.S. market for oral obesity treatments, narrowing the early lead gained by Danish rival Novo Nordisk with its Wegovy pill. Novo CEO [...]
Lilly says Foundayo has captured over 30% of new US patients on oral weight-loss drugs
By Mariam Sunny Sept 14 (Reuters) - Eli Lilly on Monday said it has captured more than 30% of new patients in the U.S. market for oral obesity treatments, narrowing the early lead gained by Danish rival Novo Nordisk with its Wegovy pill. Novo CEO Mik...
Eli Lilly Eyes Obesity Access Expansion With Zepbound, Foundayo and Pipeline Bets
Eli Lilly and Company (NYSE:LLY) is pursuing a broad obesity portfolio designed to address different patient needs across treatment initiation, maintenance, efficacy, tolerability and dosing convenience, according to Ilya Yuffa, the company’s executive vice president and president of Lilly USA and G
Pharmaceutical company Eli Lilly gets a taste of its own medicine when an industry committee finds the company guilty of making positive statements about an obesity drug in an article in Dagens Industri.
Eli Lilly stock stalls near $1,140 as Foundayo grabs 30% of new obesity-drug patients
Eli Lilly stock presents conflicting signals across timeframes. The daily chart shows cooling, while the hourly hints at stabilization. Meanwhile , Berenberg upgraded LLY on obesity drug strength, as Foundayo captured over 30% of new U.S. oral GLP-1 patients - directly challenging Novo Nordisk ....
Pharmaceutical company Eli Lilly believes it is gaining market share from competitor Novo in oral obesity treatment in the United States, Reuters reports.
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
